News
Two foundations applaud NHLBI proposal for $12 million research study on the genetics of Sarcoidosis and Alpha-1 Antitrypsin Deficiency
CHICAGO and MIAMI – The Alpha-1 Foundation and the Foundation for Sarcoidosis Research today praised the National Heart, Lung and Blood Institute of the National Institutes of Health for a planned three-year study of two serious conditions that affect the lungs: Alpha-1 Antitrypsin Deficiency (Alpha-1) and sarcoidosis.
According to the NHLBI, the research centers will “conduct state-of-the-art genomic, microbiomics and phenotypic studies” of the two conditions.
Alpha-1 is a genetic condition that can cause lung and liver disease. It is the most common known genetic cause of emphysema, which affects millions of Americans. Sarcoidosis is an inflammatory disease that can affect almost any organ in the body. In people in the United States, sarcoidosis most commonly targets the lungs and lymph nodes. The disease can affect people of any age, race and gender.
